Genome Insight: Funding, Investors & Team (Sep 2026)
Genome Insight is a company that offers whole genome sequencing services, which aims to provide a complete understanding of a patient's genetic makeup through the analysis and interpretation of their entire genome. With a primary focus on cancer and rare diseases, our goal is to revolutionize the treatment of genetically influenced illnesses by utilizing an unmatched database of whole genome sequencing information and a unified platform for generating, gathering, and examining genomic data.
Genome Insight has raised $27.5M across 2 funding rounds on record, the most recent a Series B of $23.0M announced in Nov 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genome Insight Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Genome Insight Funding Rounds
Genome Insight raised $4.5M in an undisclosed round announced in Jun 2023.
5 months later, a Series B of $23.0M was announced in Nov 2023.
Genome Insight Founders and Leadership Team
Contact details for the Genome Insight team: 1 of 2 have an email address on file.
Start 14-day free trial →Genome Insight Funding Compared to Other Biotechnology Startups
Genome Insight's latest round of $23.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genome Insight in Biotechnology and La Jolla
Companies Similar to Genome Insight
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Genome Insight Funding FAQs
What does Genome Insight do?
Genome Insight is a company that offers whole genome sequencing services, which aims to provide a complete understanding of a patient's genetic makeup through the analysis and interpretation of their entire genome. With a primary focus on cancer and rare diseases, our goal is to revolutionize the treatment of genetically influenced illnesses by utilizing an unmatched database of whole genome sequencing information and a unified platform for generating, gathering, and examining genomic data.
How much funding has Genome Insight raised?
Genome Insight has raised $27.5M across 2 rounds on record. The most recent is a Series B of $23.0M announced in Nov 2023.
When did Genome Insight last raise funding?
Genome Insight's most recent funding round on record is a Series B of $23.0M, announced in Nov 2023.
Who founded Genome Insight?
FundedIQ lists Jeong Seok Lee (Founder) at Genome Insight.
Who is the CEO of Genome Insight?
Jehee Suh is listed as CEO at Genome Insight.
Where is Genome Insight headquartered?
Genome Insight is based in La Jolla, California, United States.
How many employees does Genome Insight have?
Genome Insight is in the 51-100 employee band.
How does Genome Insight's funding compare to other Biotechnology startups?
Genome Insight's latest round of $23.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Genome Insight Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genome Insight is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.